🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Multiple myeloma represents the second most common hematological malignancy...
Status
Completed
Location
Sinai Hospital of Baltimore
Start Date
TBD
Trial ID
NCT00257114
Treatments Being Tested
This is a randomized, open-label, multi-center, phase 2 study of RCHOP with...
Status
Completed
Location
Tower Cancer Research Foundation
Start Date
2009-10
Trial ID
NCT00931918
Treatments Being Tested
Note: The study data was transferred to zr pharma\& following the divestmen...
Status
Completed
Location
Novartis Investigative Site
Start Date
2016-04-27
Trial ID
NCT02654990
Treatments Being Tested
The purpose of this study is to evaluate safety and effectiveness of CNTO 3...
Status
Completed
Location
Multiple Locations
Start Date
2009-06
Trial ID
NCT00911859
The purpose of this study is to evaluate the safety and efficacy of mitoxan...
Status
Unknown
Location
Beijing Chaoyang Hospital, Capital Medical University
Start Date
2021-10-20
Trial ID
NCT05052970
The purpose of this study is to monitor such factors as a past history, a p...
Status
Completed
Location
Multiple Locations
Start Date
2008-11
Trial ID
NCT01030302
Treatments Being Tested
This study is being done to answer the following question: Can the additio...
Status
Active Not Recruiting
Location
Alaska Oncology and Hematology LLC
Start Date
2025-08-11
Trial ID
NCT07085728
Treatments Being Tested
After the KFDA (Korea Food and Drug Administration) approval of a new drug,...
Status
Completed
Location
Multiple Locations
Start Date
2006-06
Trial ID
NCT01005628
Treatments Being Tested
The primary objective of this study is to assess the safety and tolerabilit...
Status
Completed
Location
Pacific Oncololgy & Hematology
Start Date
2009-06
Trial ID
NCT00920855
Treatments Being Tested
The purpose of the study is to compare the efficacy and safety of daratumum...
Status
Recruiting
Location
Changzhou Second People's Hospital
Start Date
2024-05-01
Trial ID
NCT06497738